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DISCUSSION: CELLULAR INJURY
DR. MACNAMEE: It is now hoped to stimulate discussion on the cellular changes
within the lung of the experimental animal for studies of chronic pulmonary diseases.
It will not be possible to agree on the one acceptable experimental animal for these
badly needed studies since such a multi-purpose animal does not exist. It must be re-
membered that there is no animal with a lung anatomically identical to that of man.
In searching for the "ideal" experimental animal lung, it is necessary to find that
species whose lungs, when exposed to relatively large concentrations of an irritant
for a short period, would react in an identical manner to the human lung exposed to
low concentrations of the irritant for many years. An animal with a normal life span
of two, five, or even ten years cannot be expected to develop the identical cellular
changes which have occurred in man's lung over his much longer life span, even if a
species which had a lung with the identical structure as that of man exists. What
then are we attempting to accomplish through this discussion of cell injury in rela-
tion to chronic pulmonary diseases? It is hoped to discuss cell injury in relation to
the experimental disease produced in the laboratory animal, recognizing that, regard-
less of the species used, it will not be possible to produce the identical pathologic
lesions seen in the human organ. However, experimentally produced cellular changes
should furnish useful data that may result in a better understanding of similar human
lung lesions. Since no species of experimental animal will manifest lesions identical
to those observed in the human lung, it is apparent that at this time there is no one
favored experimental animal for the study of cellular changes related to chronic pul-
monary diseases of man.
DR. PRATT: I wish to make a few comments about definitions of emphysema and
their implications.
First, I think almost everyone now agrees that emphysema should be defined in
terms of its pathology, not its clinical manifestations. Two such definitions are in use:
one is that emphysema is enlargement of air spaces distal to terminal bronchioles; the
second adds to the above "with destruction of their walls."
Those who prefer to use the first definition do not doubt that alveolar walls can be
destroyed in emphysema; they merely wish to include a few nondestructive diseases
or conditions under the heading of emphysema in addition to the destructive ones.
Thus when they classify the emphysemas, they begin with two large groups: non-
destructive and destructive. Those who use the second definition would not apply the
term emphysema to those diseases which would be listed under the heading "non-
destructive emphysema." A specific example would be pulmonary overdistension,
which would be called emphysema under the first definition and not under the second.
Centrilobular emphysema, the most common form, is recognized by all of us as being
destructive of tissue no matter which definition we use.
When we attempt to develop an experimental model for emphysema, we must have
clearly in mind what it is we are after. The form of emphysema which is causing
most of the morbidity and mortality today is centrilobular emphysema. It is this
disease for which we need an experimental model. Studies of experimental pulmonary
overdistension, even though it can be called emphysema, will not advance our knowl-
edge of centrilobular emphysema.
Thus it is important for those who are attempting to produce emphysema in ex-
perimental animals to demonstrate destruction of pulmonary tissue distal to terminal
bronchioles. The very best way to demonstrate this is with thick, three dimensional
sections of the animal lungs which have been fixed in inflation by any of several well-
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known techniques. When tissue destruction is present, such preparations will demon-
strate it incontrovertibly, revealing the pattern of distribution and the extent of the
change.
DR. GROSS: I would like to present to you a particular model dealing with alveolar
proteinosis as it is pertinent to the discussion of the first paper.
It is my concept that alveolar proteinosis represents essentially a disturbance of the
alveolar clearance mechanism. I believe that Liebow, as well as Heppleston and Gough,
have emphasized that the proteinaceous material in the alveoli of alveolar proteinosis
is derived mostly from the alveolar macrophages. In our experience, rats or guinea
pigs inhaling very large concentrations of unetched quartz dust developed alveolar
proteinosis instead of silicosis, with very little inflammatory reaction.
The characteristic finding in these animals are alveoli filled with acidophilic, granu-
lar, PAS-positive material. At the same time, the alveolar walls are thin and delicate.
There is no inflammatory reaction, and when sections are incinerated, the alveoli, in
addition to containing proteinaceous material, are found to be filled with quartz dust.
In many regions, the granular proteinaceous material contains nuclear fragments and
occasional macrophages. In some foci, the proteinaceous material is associated with
a small number of well-preserved macrophages and the alveolar walls show an in-
creased cellularity.
A somewhat different, but related, picture is found in regions where alveoli are
little else but well-preserved macrophages. Proteinaceous material, when present here,
is minimal. It is in these regions that occasional, small and abortive silicotic nodules
are found associated with thickened and cellular alveolar walls. Incineration of such
sections shows that the macrophages contain abundant quartz dust.
DR. KILBURN: Do those cells in the alveoli clear the proteinaceous material?
DR. GROSS: We believe these cells are the response to the presence of quartz dust.
Rather than the cells being there as the result of the presence of proteinaceous ma-
terial, I think the cells contribute to the proteinaceous material.
DR. KLEINERMAN: What was the size of the quartz particles used in your ex-
periment and how long after exposure were specimens taken?
DR. GROSS: The quartz had an average surface mean diameter of 2.3 microns.
The animals had a total exposure of 150 days, six hours a day five days a week, to a
dust concentration of 250 milligrams per cubic meter. Specimens were taken anywhere
from seven to fifteen months later.
DR. GARETH GREEN: Do I understand that this is a constant finding in silica
animals? Do you find granulomatous responses in the same animals? How does the
treatment differ so that on the one hand you get this picture and on the other hand a
granulomatous response?
DR. GROSS: The granulomatous response was obtained with the same dust with
a concentration of 30 milligrams per cubic meter. I believe that the difference in re-
action is caused by the astronomically high dust exposure in the present investigation.
I have no explanation at the present time for the failure of the alveolar wall to respond
with the formation of silicotic nodules.
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DR. SAFFIOTTI: It looks as if the lesions had been blocked at the stage of al-
veolar necrosis, and somehow prevented from progressing further to the other stages.
It is very interesting.
DR. GROSS: I am considering that the proteinaceous material coated the quartz
particles and prevented the development of silicotic nodules.
DR. LANDY: Dr. Gross, the proteinaceous material to which you refer may be
analogous to that reported by Vigliani and Pernis, the group in Milan, studying
silicotic nodules. In this case it was shown very convincingly in man, at least, that
this was pure immunoglobulin.
DR. GROSS: It seems to me that the findings in our animals somewhat opposed
the immunologic theory of Pernis and Vigliani inasmuch as their theory postulates
that the lipoprotein complexes form as a result of the action of quartz dust on the
macrophage-that this lipoprotein is antigenic and, therefore, it should be productive
of an inflammatory response. This, however, is absent here.
DR. LANDY: The other interesting point in the Italian work is that it was shown
very clearly that hydrochloric acid etched silica was highly cytotoxic, unusually so
for macrophages, while the amorphous material was not. Yet it is largely the amorph-
ous material with which you are working which gives this reaction.
DR. GROSS: I might say when this same quartz dust was injected intratracheally
into animals in a dose of 50 milligrams, classical silicosis resulted.
DR. KILBURN: Isn't this an example of inability of the alveoli to initiate the first
stage of clearance? If you give a smaller dose, then presumably the lymphatic side on
the clearance chain functions to result in a focus of cell damage and the development
of a granuloma. If this is true, one should find granulomatous formation and some
proteinaceous formation between doses. Have you done that kind of intermediate
experiment?
DR. GROSS: No, but I can tell you that there is massive transport of the dust to
lymph nodes which are greatly enlarged and fibrotic.
DR. SAFFIOTTI: I wonder if there may be some factor inherent in the animals
used. One of the elements of the reaction that seems to have some role in the final
genesis of fibrosis is the role of mast cells. In syrian golden hamsters that we have
used for other purposes, I find very few mast cells in the rubbings. In the presence of
silica, the mast cells are scarce. The cellular reaction remains mostly macrophagic
with very little fibrosis for a much longer period of time than occurs in normal rats
which have been exposed to chronic infections and have many mast cells.
Is the mast cell reaction present in these animals?
DR. GROSS. I did not study mast cells in these animals; however, the same pro-
teinosis is found in guinea pigs. Some of the sections that you saw were from guinea
pigs as well as from rats. Furthermore, last year we reported a similar focal pro-
teinosis in hamsters injected intratracheally with quartz dust. A year previous to that,
we reported foci of alveolar proteinosis in rats that had received X-ray irradiation of
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the chest. I believe the X-ray treatment, for example, interfered with alveolar clear-
ance just as the excessive silica exposure did.
I have stated that it is my belief that alveolar proteinosis represents a combination
of clearance failure with an excessive production of alveolar macrophages. There is
the possibility of a deficiency in proteolytic enzymes which under ordinary circum-
stances may solubilize the proteins.
DR. VORWALD: Did you find, even after 15 months exposure to quartz dust,
any evidence of granulomatous change in the alveolar septa?
DR. GROSS: That is essentially correct. There were a few rudimentary silicotic
nodules, very small ones. The animals died at various intervals, but my longest sur-
vival was 15 months. Rats, guinea pigs, and hamsters were used.
DR. VORWALD: I am wondering, however, whether this alveolar proteinosis is
a specific response or whether this is a more or less nonspecific universal response to
any type injury to the alveolar septa imposed by a toxic substance.
DR. GROSS: I have experience with a large variety of alveolar irritants. This is
the first time I have encountered a situation or a response which resembles energy;
that is, where there is no inflammatory response to a known violent irritant. So, to
answer your question, I do not believe it is a general response. It is apparently a re-
sponse to a specific set of conditions in this case.
DR. TYLER: I would like to make some remarks concerning the organization of
the lung.
We are talking about animal models of human disease. Claude Bernard and Albert
Szent-Gyorgyi have clearly indicated that organization of units is a very important
concept in experimental models. According to Dr. John West's Handbook of Physiol-
ogy, in a lung the size of that of man or a Greyhound dog in the upright position,
there are three zones of perfusion by the pulmonary artery. Zone 1, at the top of the
lung, is not perfused under Dr. West's experimental conditions. Dr. West has also
demonstrated differences in ventilation and alveolar size in the various zones.
I believe that the lung of the experimental animal must be at least as large as man's
so that this now well-known effect of gravity on pulmonary blood flow can be taken
into account. It is not a significant factor in the rat, in the mouse, or in the guinea
pig. It may be a significant factor in large dogs. It is a significant factor in man, a
fact we cannot ignore.
DR. KILBURN: I would like to respond to Walt Tyler's suggestion and point out
that gravity certainly is not the only determinant force in perfusion of the lung. If
one considers that the lung has an extremely acid environment, at least on its sur-
face, as demonstrated by Streye and others, lung fluids have virtually no biocarbonate
and thus are virtually unbuffered. The body of evidence supporting the notion that
acid is a controlling mechanism in pulmonary flow relates to Dr. Carrington's beauti-
ful presentation, and suggests that what we have called the "alveolar capillary block
syndrome" has not anything to do with the block across capillaries, but rather it is
a loss of unit perfusion at the level of arterioles because of a change in environment.
i.e., increased acidity. And the source of this acidity is the cells, as Drs. Gross and
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Carrington have shown, which alter the environment when damaged. Obstruction of
perfusion results in a poorly oxygenated area-a micro-alien environment in the
midst of plenty. It is a bit like the rhyme of the Ancient Mariner, "Water, water
everywhere, but not a drop to drink."
After all, the lung is a massive endothelial organ. We forget that the lung is a
latticework for the endothelium. This concept alone should help explain a lot of
things that have been inexplicable in talking of alveolar cell and macrophage responses.
Thus, ischemia or relative perfusion richness are very important in the lung's response
beyond the short-term viability of a cell cut off from its blood supply.
DR. BOREN: I think that as far as ventilation is concerned, it really makes no
difference whether lung is one large sac or many small sacs. What is important is the
perfusion and how it is accomplished. I think this is the importance of Tenney and
Remmers' work. As we consider smaller animals with their high oxygen requirement,
more partitioning with greater vascularization is seen, thereby allowing perfusion to
occur at normal pressures.
I think that perhaps Dr. Tyler overemphasizes the effect of total body size on lung
volume when one considers the mechanism of increasing partitioning which keeps
perfusion pressures low.
DR. TYLER: I think we are still overlooking this effect of gravity, and we are
overlooking its correlation with the location of early lesions of emphysema in humans.
It seems to me that the upper lobe has a greater incidence of lesions, at least in the
early stages of the disease. Further, I don't really think that we have measured these
pressures.
DR. BOREN: No. It is true that the waterfall effect such as you are describing
occurs, but I don't think this has been studied in small animals.
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